Gene Query: STK16

Dataset Description Geneva Score
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 29.87
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 13.09
SETBP1-WT and SETBP1-G870S epigenetic landscapes 11.92
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 11.92
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 9.54
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.06
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 8.22
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 7.87
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 7.65
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 7.65
U1 snRNP telescripting regulates size-function stratified human genome 7.46
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 7.12
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.99
Tracking of dCas9-methyltransferase footprints 6.66
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 6.3
CROP-Seq in Primary Human T Cells 6.03
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 5.56
Identification of Sin3B regulated genes during quiescence 5.55
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 5.02
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 5.02
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 4.8
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 4.8
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.8
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 4.74
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 4.62
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 4.54
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 4.54
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.52
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.51
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.46
RNA-seq of IL-4 stimulated human keratinocytes 4.38
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.25
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 4.14
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.12
Peptidomimetic blockade of MYB in acute myeloid leukemia 4.07
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 4.07
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 3.99
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.97
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 3.96
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 3.74
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 3.74
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.72
RNA-seq analysis of uveal melanoma cells treated with FR900359 3.69
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 3.68
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 3.68
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.63
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.6
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.59
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 3.51
FOXD3 is a novel tumor suppressor in lung cancer 3.5
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.48
RNA-seq differential expression studies: more sequence, or more replication? 3.43
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 3.41
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.39
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 3.28
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.2
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.14
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.14
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.09
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.0
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.96
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 2.94
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 2.88
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.87
HNF1A deficiency impairs β-cell fate, granule maturation and function 2.82
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.81
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 2.81
The evolution of N6-methyladenosine in primates 2.81
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 2.76
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.74
NR2F2 study 2.74
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 2.72
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.71
Active translatome profiling with RiboLace in MCF7 cells 2.7
DRB/GRO-Seq -/+ UV 2.7
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.68
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.67
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 2.65
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.65
T47D RNA-seq and ChrRNA-seq data 2.65
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 2.64
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 2.64
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 2.64
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.63
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 2.61
Transcriptome analysis of SKI knock-out in HL60 cells 2.58
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.58
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.58
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 2.57
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.55
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 2.55
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 2.55
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 2.54
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.53
Tumor exosome integrins determine organotropic metastasis 2.53
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.53
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 2.52
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.5
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 2.5
HEK293 TFAM Knockout Expression Study 2.46
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 2.44
EP400 is required for Max and MCPyV mediated gene activation 2.39
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.37
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.37
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 2.36
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.32
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.29
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 2.28
Modulation of nonsense-mediated decay by rapamycin 2.25
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 2.25
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 2.25
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 2.24
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.24
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 2.24
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 2.23
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.23
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 2.21
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.2
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.2
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.2
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.19
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 2.18
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.16
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.15
RNAseq of HEK293 cells after Chtop knockdown 2.14
Co-transcriptional loading of RNA export factors shapes the human transcriptome 2.14
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.14
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.12
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.11
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.1
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 2.08
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 2.08
Regulating Interleukin-2 activity with engineered receptor signaling clamps 2.07
Global analysis of enhancer targets: Mosaic-seq 2.06
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 2.06
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 2.06
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 2.05
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.03
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.03
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 2.02
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 2.02
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.02
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.02
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.01
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.98
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 1.97
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 1.97
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 1.97
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 1.94
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.93
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.92
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.92
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.92
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 1.89
Regulatory network controlling tumor-promoting inflammation in human cancers 1.88
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.88
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.88
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.87
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.85
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 1.84
ETV7 and interferon response 1.84
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.83
LncRNA expression profiling of ischemic stroke patients 1.81
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.8
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 1.78
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 1.78
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 1.78
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 1.76
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.75
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 1.75
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 1.75
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.75
Identification of transcription start sites for human A549 cell line using ReCappable-seq 1.75
Pharmacologic inhibition of STAT5 in AML 1.74
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.74
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.73
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.73
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 1.73
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.72
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.71
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.71
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.71
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 1.7
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 1.67
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 1.67
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 1.67
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.67
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 1.66
Transcriptome-wide identification of CELF2 functional targets in T cells 1.65
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 1.65
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 1.65
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.65
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.64
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.64
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 1.62
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 1.62
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 1.62
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 1.61
LIN28A Over-expression RNAseq 1.6
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.6
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.6
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.59
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 1.58
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.56
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.56
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 1.55
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.54
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.54
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 1.54
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 1.53
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 1.53
RNA-Seq and expression data from human adipose tissue 1.51
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.51
The comparison of high-throughput single-cell RNA-seq methods 1.5
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.49
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.49
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.49
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 1.48
The circadian transcriptional landscape in primary human mammary epithelial cells 1.48
Impact of dieldrin on transcription in Jurkat T cells 1.47
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.47
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.47
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 1.46
Clinker: visualizing fusion genes detected in RNA-seq data 1.45
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.45
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.45
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 1.45
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.44
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.43
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 1.42
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.42
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 1.42
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 1.4
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.39
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.38
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.38
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.38
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.38
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 1.37
Expression level comparison under dividing and quiescent states in human primary fibroblasts 1.37
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.37
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.36
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.34
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.34
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.34
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 1.33
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 1.31
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 1.31
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 1.31
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.31
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 1.3
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 1.3
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 1.3
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 1.29
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 1.29
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.28
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 1.28
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.26
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 1.26
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.23
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 1.23
Global epigenomic reconfiguration during mammalian brain development 1.23
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.21
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 1.21
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.21
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.2
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.2
High-throughput sequencing of pluripotent cells 1.2
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 1.2
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.19
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.19
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.18
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.18
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.18
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 1.17
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.17
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 1.16
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.16
Exploring ILF2 regulatory genes by next-generation sequencing 1.15
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 1.15
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.14
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.14
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 1.13
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.13
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 1.12
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.12
Energy Metabolism during Anchorage-Independence 1.11
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 1.11
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.11
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.11
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.1
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.09
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.09
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.08
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.08
Identification of long noncoding RNAs in T-ALL cell lines 1.08
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 1.07
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.07
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.07
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.07
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.06
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.06
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.04
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.03
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 1.02
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.02
RNA-seq of naive and primed ES cells (NHSM) 1.01
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 1.0
Global expression profiles in cardiac progenitor cells generated by ISX-9 1.0
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 1.0
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 0.99
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.99
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.99
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.98
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.98
Androgen Receptor-regulated genes in prostate cancer cells 0.98
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.97
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.97
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.97
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.92
Controlling for gene expression changes in transcription factor protein networks. 0.92
Investigate A2M treatment on human prostate cancer and mouse liver 0.9
Investigate A2M treatment on human prostate cancer xenograft in mice 0.9
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.9
RNA-seq analysis of BAP1-depleted uveal melanoma cells 0.88
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.87
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.87
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.87
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 0.87
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.85
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 0.85
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.85
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.85
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.84
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.83
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.83
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 0.83
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.82
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.82
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.82
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.82
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 0.81
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.81
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.8
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 0.8
RNA-sequencing of healthy human skeletal myocytes 0.8
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.79
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.79
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.79
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 0.78
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.77
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.76
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 0.76
Discovering human diabetes-risk gene function with genetics and physiological assays 0.76
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.75
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 0.74
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.74
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.71
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.71
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.7
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.7
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.69
RNA-Seq from human ILC transitional populations 0.69
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.66
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.64
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.63
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.63
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.62
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.62
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 0.61
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 0.61
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.61
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.61
Functional significance of the HIV-1 Tat signature amino acid residues 0.61
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.6
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.59
Single cell transcriptome of peritoneal cells 0.59
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.59
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.59
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.58
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.58
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.58
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.58
RNA-seq analysis of differentiating human erythroblasts 0.57
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 0.56
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.56
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.54
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.54
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.54
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.54
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.53
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.53
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.53
Ribosome profiling upon inhibition of eIF4A 0.53
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.52
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.52
Measure transcript integrity using RNA-seq data 0.52
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.51
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.51
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.49
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.49
Leucegene: ALL sequencing 0.48
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.47
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.46
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.46
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.44
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.43
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.43
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.42
Illumina Total RNA-seq in HeLa 0.42
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.4
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.4
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.37
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.36
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.36
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.36
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.34
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.34
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.33
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.33
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.33
Myc activation coordinates gene transcription and protein translation responses 0.33
RNAseq of cell lines with knocked in ESR1 mutations 0.33
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.32
Analyses of T-ALL (COG study) 0.32
RNA sequencing of T-ALL (COG study) 0.32
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.32
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.3
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.3
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.3
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.29
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.29
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 0.28
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.27
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.27
Targeted enhancer activation by a subunit of the integrator complex 0.26
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.26
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.26
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.26
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.26
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.26
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.26
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.25
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.24
miRNAs affected by antagomiR-17 treatment 0.24
Identification of a LIF-responsive replication-competent human β cell 0.23
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.23
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.23
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.23
SLAM-seq for K562 endogenous mRNA decay 0.22
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.22
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.22
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.22
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.19
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.19
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.19
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.19
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.18
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.18
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.18
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.17
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.17
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.17
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.16
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 0.15
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.14
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.14
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.13
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.13
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.13
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.13
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.12
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.12
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.11
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.11
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.11
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 0.11
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.1
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.1
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.09
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.09
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.06
High-resolution comparative analysis of great ape genomes 0.05
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.05
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.04
quanTIseq: quantifying immune contexture of human tumors 0.04
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.04
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.03
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.03
Metabolism as an early predictor of DPSCs aging 0.03
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.02
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.01
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.01
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.0
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.0
Comparative Analysis of Cas9 Activators Across Multiple Species 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation